688739 成大生物
已收盘 12-17 15:00:00
资讯
新帖
简况
成大生物：拟续聘致同会计师事务所为2025年度审计机构
证券日报网 · 12-07
成大生物：拟续聘致同会计师事务所为2025年度审计机构
成大生物（688739）披露以集中竞价交易方式回购公司股份的进展公告，12月01日股价上涨0.15%
证券之星 · 12-01
成大生物（688739）披露以集中竞价交易方式回购公司股份的进展公告，12月01日股价上涨0.15%
每周股票复盘：成大生物（688739）将召开2025年第三季度业绩说明会
证券之星 · 11-23
每周股票复盘：成大生物（688739）将召开2025年第三季度业绩说明会
成大生物（688739）披露召开2025年第三季度业绩说明会，11月20日股价下跌0.26%
证券之星 · 11-20
成大生物（688739）披露召开2025年第三季度业绩说明会，11月20日股价下跌0.26%
每周股票复盘：成大生物（688739）已回购38.49万股耗资1078.92万元
证券之星 · 11-09
每周股票复盘：成大生物（688739）已回购38.49万股耗资1078.92万元
成大生物（688739）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价上涨0.29%
证券之星 · 11-03
成大生物（688739）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价上涨0.29%
成大生物（688739）披露2025年第三季度报告，10月30日股价下跌1.09%
证券之星 · 10-30
成大生物（688739）披露2025年第三季度报告，10月30日股价下跌1.09%
图解成大生物三季报：第三季度单季净利润同比下降61.17%
证券之星 · 10-29
图解成大生物三季报：第三季度单季净利润同比下降61.17%
成大生物(688739.SH)与中国科学院微生物研究所签订战略合作协议
智通财经 · 10-21
成大生物(688739.SH)与中国科学院微生物研究所签订战略合作协议
每周股票复盘：成大生物（688739）9月回购208,478股
证券之星 · 10-12
每周股票复盘：成大生物（688739）9月回购208,478股
成大生物（688739）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价上涨0.93%
证券之星 · 10-09
成大生物（688739）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价上涨0.93%
成大生物（本溪）取得适用于超滤系统气密性检测装置专利，减少漏气风险
金融界 · 08-30
成大生物（本溪）取得适用于超滤系统气密性检测装置专利，减少漏气风险
成大生物（688739）2025年中报简析：净利润同比下降44.47%
证券之星 · 08-30
成大生物（688739）2025年中报简析：净利润同比下降44.47%
图解成大生物中报：第二季度单季净利润同比下降63.91%
证券之星 · 08-29
图解成大生物中报：第二季度单季净利润同比下降63.91%
成大生物：2025年上半年净利润1.22亿元，同比下降44.47%
金融界 · 08-28
成大生物：2025年上半年净利润1.22亿元，同比下降44.47%
每周股票复盘：成大生物（688739）取消监事会并修订公司章程
证券之星 · 08-17
每周股票复盘：成大生物（688739）取消监事会并修订公司章程
生物制品行业盘中跳水，成大生物跌0.35%
市场透视 · 08-12
生物制品行业盘中跳水，成大生物跌0.35%
每周股票复盘：成大生物（688739）计划回购股份1000万至2000万元
证券之星 · 08-10
每周股票复盘：成大生物（688739）计划回购股份1000万至2000万元
成大生物：尚未实施本次股份回购计划
格隆汇 · 08-04
成大生物：尚未实施本次股份回购计划
生物制品行业点评报告-减重赛道全球前沿进展跟踪(一)：AMYLIN布局正当时
开源证券 · 08-04
生物制品行业点评报告-减重赛道全球前沿进展跟踪(一)：AMYLIN布局正当时
公司概况
公司名称：
辽宁成大生物股份有限公司
所属行业：
医药制造业
上市日期：
2021-10-28
主营业务：
辽宁成大生物股份有限公司的主营业务是人用疫苗的研发、生产与销售。公司的主要产品是人用狂犬病疫苗和人用乙脑灭活疫苗。
发行价格：
110.00
{"stockData":{"symbol":"688739","market":"SH","secType":"STK","nameCN":"成大生物","latestPrice":26.05,"timestamp":1765954800000,"preClose":25.91,"halted":0,"volume":1299512,"delay":0,"changeRate":0.0054,"floatShares":416000000,"shares":416000000,"eps":0.4273,"marketStatus":"已收盘","change":0.14,"latestTime":"12-17 15:00:00","open":25.83,"high":26.17,"low":25.72,"amount":33659500,"amplitude":0.0174,"askPrice":26.08,"askSize":15,"bidPrice":26.05,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.4273,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":25.91,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":28.5,"lowLimit":23.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":416450000,"isCdr":false,"pbRate":1.16,"roa":"--","peRate":60.964194,"roe":"1.74%","epsLYR":0.83,"committee":0.09901,"marketValue":10849000000,"turnoverRate":0.0031,"status":0,"afterMarket":{"amount":0,"volume":0,"close":26.05,"buyVolume":0,"sellVolume":0,"time":1765956837768,"indexStatus":"已收盘 12-17 15:30:00","preClose":25.91},"floatMarketCap":10849000000},"requestUrl":"/m/hq/s/688739/wiki","defaultTab":"wiki","newsList":[{"id":"2589870507","title":"成大生物：拟续聘致同会计师事务所为2025年度审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870507","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589870507?lang=zh_cn&edition=full","pubTime":"2025-12-07 20:38","pubTimestamp":1765111080,"startTime":"0","endTime":"0","summary":"证券日报网讯12月5日晚间，成大生物发布公告称，公司拟续聘致同会计师事务所(特殊普通合伙)为2025年度财务报告及内部控制审计机构，审计费用总额不超过70万元，其中财务审计费用55万元、内控审计费用15万元，与2024年度持平，该事项尚需12月23日股东会审议通过。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyxcz3133457.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyxcz3133457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2588775666","title":"成大生物（688739）披露以集中竞价交易方式回购公司股份的进展公告，12月01日股价上涨0.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588775666","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588775666?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:27","pubTimestamp":1764599257,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，成大生物报收于26.8元，较前一交易日上涨0.15%，最新总市值为111.61亿元。该股当日开盘26.69元，最高26.88元，最低26.67元，成交额达3561.89万元，换手率为0.32%。近日，辽宁成大生物股份有限公司发布关于以集中竞价交易方式回购公司股份的进展公告。公司表示，本次回购进展符合相关法律法规及公司回购方案的规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100036951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2585477103","title":"每周股票复盘：成大生物（688739）将召开2025年第三季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2585477103","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585477103?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:53","pubTimestamp":1763837589,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，成大生物报收于26.48元，较上周的28.17元下跌6.0%。本周，成大生物11月17日盘中最高价报28.39元。公司公告汇总辽宁成大生物股份有限公司将于2025年11月28日上午9:00-10:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会，介绍公司2025年第三季度报告的经营成果和财务状况。投资者可于2025年11月21日至11月27日16:00前通过上证路演中心网站或公司邮箱提交问题，公司在说明会上将对普遍关注的问题进行回应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2584713052","title":"成大生物（688739）披露召开2025年第三季度业绩说明会，11月20日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584713052","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584713052?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:23","pubTimestamp":1763648599,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，成大生物报收于27.28元，较前一交易日下跌0.26%，最新总市值为113.61亿元。公司近日发布公告称，辽宁成大生物股份有限公司将于2025年11月28日上午9:00-10:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会，介绍公司2025年第三季度报告的经营成果和财务状况。投资者可于2025年11月21日至11月27日16:00前通过上证路演中心网站或公司邮箱提交问题，公司在说明会上将对普遍关注的问题进行回应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000038257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2582886481","title":"每周股票复盘：成大生物（688739）已回购38.49万股耗资1078.92万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582886481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582886481?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:39","pubTimestamp":1762634348,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，成大生物报收于27.43元，较上周的27.42元上涨0.04%。本周，成大生物11月4日盘中最高价报27.66元。本周关注点公司公告汇总：截至2025年10月31日，成大生物已累计回购股份384,899股，支付资金总额10,789,216.56元。2025年10月未进行回购操作。后续公司将根据市场情况择机推进回购，并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2580142362","title":"成大生物（688739）披露以集中竞价交易方式回购公司股份的进展公告，11月03日股价上涨0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580142362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580142362?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:48","pubTimestamp":1762181306,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，成大生物报收于27.5元，较前一交易日上涨0.29%，最新总市值为114.52亿元。该股当日开盘27.41元，最高27.56元，最低27.33元，成交额达6103.61万元，换手率为0.53%。近日，辽宁成大生物股份有限公司发布关于以集中竞价交易方式回购公司股份的进展公告。上述回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300036393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2579116650","title":"成大生物（688739）披露2025年第三季度报告，10月30日股价下跌1.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579116650","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579116650?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:59","pubTimestamp":1761818362,"startTime":"0","endTime":"0","summary":"近日，成大生物发布《2025年第三季度报告》，披露了公司前三季度主要财务数据。公告显示，年初至报告期末公司实现营业收入1,095,886,627.32元，较上年同期减少15.88%；归属于上市公司股东的净利润为164,812,017.55元，较上年同期减少50.01%。研发投入方面，年初至报告期末研发投入合计为309,677,910.03元，较上年同期减少13.68%；研发投入占营业收入的比例为28.26%，较上年同期增加0.72个百分点。截至2025年9月30日，公司回购专用证券账户持股数为5,199,548股，占公司总股本的1.25%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000035472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2579971649","title":"图解成大生物三季报：第三季度单季净利润同比下降61.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579971649","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579971649?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:47","pubTimestamp":1761734820,"startTime":"0","endTime":"0","summary":"证券之星消息，成大生物2025年三季报显示，前三季度公司主营收入10.96亿元，同比下降15.88%；归母净利润1.65亿元，同比下降50.01%；扣非净利润1.35亿元，同比下降56.77%；其中2025年第三季度，公司单季度主营收入3.89亿元，同比下降7.79%；单季度归母净利润4251.73万元，同比下降61.17%；单季度扣非净利润3288.14万元，同比下降67.53%；负债率4.24%，投资收益2037.55万元，财务费用-2861.52万元，毛利率79.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"gpt_icon":0},{"id":"2577784281","title":"成大生物(688739.SH)与中国科学院微生物研究所签订战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2577784281","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577784281?lang=zh_cn&edition=full","pubTime":"2025-10-21 16:08","pubTimestamp":1761034095,"startTime":"0","endTime":"0","summary":"智通财经APP讯，成大生物(688739.SH)发布公告，公司与中国科学院微生物研究所(简称“微生物所”)于近日签署《战略合作协议》，双方聚焦新发突发传染病领域，重点围绕虫媒传染病预防，联合申报国家级、省部级科研项目，协同发力应对传染病防控。此次协议属于意向性合作范畴，对公司2025年度及未来业绩不构成直接影响，对公司业绩的具体影响需视下一步具体项目推进和实施情况来确定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"成大生物(688739.SH)与中国科学院微生物研究所签订战略合作协议","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2574645021","title":"每周股票复盘：成大生物（688739）9月回购208,478股","url":"https://stock-news.laohu8.com/highlight/detail?id=2574645021","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574645021?lang=zh_cn&edition=full","pubTime":"2025-10-12 02:45","pubTimestamp":1760208315,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，成大生物报收于27.3元，较上周的26.9元上涨1.49%。本周，成大生物10月10日盘中最高价报27.48元。公司公告汇总：截至2025年9月30日，累计回购384,899股，占总股本0.092%。截至2025年9月30日，已累计回购股份384,899股，占公司总股本的0.092%，支付资金总额10,789,216.56元，回购最高价为29.61元/股，最低价为27.20元/股。2025年9月单月回购208,478股，支付资金5,748,133.70元。上述回购行为符合相关规定，公司将持续推进回购并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2574563161","title":"成大生物（688739）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价上涨0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574563161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574563161?lang=zh_cn&edition=full","pubTime":"2025-10-09 23:10","pubTimestamp":1760022624,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，成大生物报收于27.15元，较前一交易日上涨0.93%，最新总市值为113.07亿元。近日，辽宁成大生物股份有限公司发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，公司于2025年6月19日召开董事会审议通过回购股份方案，拟使用超募资金1,000万元至2,000万元，以集中竞价交易方式回购股份，用于员工持股计划或股权激励，回购价格不超过38.00元/股，实施期限为2025年6月19日至2026年6月18日。上述回购符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900035064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2563100524","title":"成大生物（本溪）取得适用于超滤系统气密性检测装置专利，减少漏气风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2563100524","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563100524?lang=zh_cn&edition=full","pubTime":"2025-08-30 09:03","pubTimestamp":1756515831,"startTime":"0","endTime":"0","summary":"国家知识产权局信息显示，成大生物（本溪）有限公司取得一项名为“一种适用于超滤系统气密性检测装置”的专利，授权公告号CN 223272095 U，申请日期为2024年11月。天眼查资料显示，成大生物（本溪）有限公司，成立于2021年，位于本溪市，是一家以从事医药制造业为主的企业。通过天眼查大数据分析，成大生物（本溪）有限公司参与招投标项目21次，专利信息32条，此外企业还拥有行政许可267个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/30090352823694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2563070638","title":"成大生物（688739）2025年中报简析：净利润同比下降44.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563070638","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563070638?lang=zh_cn&edition=full","pubTime":"2025-08-30 06:19","pubTimestamp":1756505986,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期成大生物发布2025年中报。根据财报显示，成大生物净利润同比下降44.47%。截至本报告期末，公司营业总收入7.07亿元，同比下降19.75%，归母净利润1.22亿元，同比下降44.47%。按单季度数据看，第二季度营业总收入3.48亿元，同比下降32.48%，第二季度归母净利润5007.67万元，同比下降63.91%。然而去年的净利率为20.45%，算上全部成本后，公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083000010737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"gpt_icon":0},{"id":"2563050228","title":"图解成大生物中报：第二季度单季净利润同比下降63.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563050228","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563050228?lang=zh_cn&edition=full","pubTime":"2025-08-29 01:49","pubTimestamp":1756403397,"startTime":"0","endTime":"0","summary":"证券之星消息，成大生物2025年中报显示，公司主营收入7.07亿元，同比下降19.75%；归母净利润1.22亿元，同比下降44.47%；扣非净利润1.02亿元，同比下降51.6%；其中2025年第二季度，公司单季度主营收入3.48亿元，同比下降32.48%；单季度归母净利润5007.67万元，同比下降63.91%；单季度扣非净利润3941.21万元，同比下降72.31%；负债率4.41%，投资收益1326.7万元，财务费用-2163.43万元，毛利率79.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082900000646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"gpt_icon":0},{"id":"2562653036","title":"成大生物：2025年上半年净利润1.22亿元，同比下降44.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562653036","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562653036?lang=zh_cn&edition=full","pubTime":"2025-08-28 19:11","pubTimestamp":1756379483,"startTime":"0","endTime":"0","summary":"成大生物公告，2025年上半年营业收入7.07亿元，同比下降19.75%。净利润1.22亿元，同比下降44.47%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/28191152783771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688739"],"gpt_icon":0},{"id":"2560592570","title":"每周股票复盘：成大生物（688739）取消监事会并修订公司章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2560592570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560592570?lang=zh_cn&edition=full","pubTime":"2025-08-17 04:20","pubTimestamp":1755375617,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘，成大生物报收于29.02元，较上周的28.69元上涨1.15%。本周关注点公司公告汇总：成大生物取消监事会并修订公司章程，相关议案将提交股东会审议。辽宁成大生物股份有限公司将于2025年8月28日9点30分召开2025年第一次临时股东会，审议取消监事会、废止《监事会议事规则》并修订《公司章程》及其附件，制定公司董事和高级管理人员薪酬管理制度，选举徐飚先生和周岳先生为第五届董事会非独立董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2558455697","title":"生物制品行业盘中跳水，成大生物跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558455697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558455697?lang=zh_cn&edition=full","pubTime":"2025-08-12 10:40","pubTimestamp":1754966408,"startTime":"0","endTime":"0","summary":"08月12日，生物制品行业盘中跳水，截至10点40分，生物制品行业整体指数下跌1.01%，报6884.300点。从个股上来看，该行业的成分股中，成大生物跌0.35%，长春高新、万泰生物、上海莱士跌幅居前。从资金上来看，截止发稿，生物制品行业主力净流入为-3.27亿，其中西藏药业受到资金热捧，主力净流入2.03亿；拉长时间线来看，该板块近20日主力资金净流入-45.53亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081210400897420a71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081210400897420a71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","600211","688739","603392"],"gpt_icon":0},{"id":"2558507232","title":"每周股票复盘：成大生物（688739）计划回购股份1000万至2000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558507232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558507232?lang=zh_cn&edition=full","pubTime":"2025-08-10 03:04","pubTimestamp":1754766256,"startTime":"0","endTime":"0","summary":"本周关注点成大生物计划以集中竞价交易方式回购股份，金额为1000万元至2000万元公司公告汇总成大生物计划以集中竞价交易方式回购股份，回购方案首次披露日为2025年6月19日，实施期限为2025年6月19日至2026年6月18日。预计回购金额为1000万元至2000万元，回购用途为用于员工持股计划或股权激励。公司将根据回购股份事项进展情况及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081000000529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"gpt_icon":0},{"id":"2556633801","title":"成大生物：尚未实施本次股份回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2556633801","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556633801?lang=zh_cn&edition=full","pubTime":"2025-08-04 15:33","pubTimestamp":1754292810,"startTime":"0","endTime":"0","summary":"格隆汇8月4日丨成大生物(688739.SH)公布，截至2025年7月31日，公司尚未实施本次股份回购计划，公司后续将根据市场情况择机实施本次回购计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080415333894ce32d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080415333894ce32d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688739"],"gpt_icon":0},{"id":"2556879631","title":"生物制品行业点评报告-减重赛道全球前沿进展跟踪(一)：AMYLIN布局正当时","url":"https://stock-news.laohu8.com/highlight/detail?id=2556879631","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556879631?lang=zh_cn&edition=full","pubTime":"2025-08-04 00:00","pubTimestamp":1754236800,"startTime":"0","endTime":"0","summary":"近期重磅BD 交易总结艾伯维和罗氏先后在2025 年一季度花重金布局amylin 分子。艾伯维将支付首付款3.5 亿美金，里程碑高达18.75 亿美金，以及销售分成。高质量减重方面，临床前DIO 大鼠数据显示Eloralintide 减少的体重最高达91%为脂肪。而目前GLP-1 类药物减重中约20%-40%为瘦体重。此外，礼来在ADA 大会上表示未来不排除eloralintide 开发月度制剂的可能性。Metsera 公司明确MET-223i 将定位为月度制剂。值得指出的是，Structure 和众生药业以小分子形式切入了amylin 赛道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804093615a4733c3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804093615a4733c3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603590","688163","688278","600211","688670","688443","688687","688319","688739","600161","BK0239","688293","688336","688520","688166","688488","603087","688177","688105","603392","600867","600739","688276","688137"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765999140634,"stockEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0696},{"period":"3month","weight":-0.0412},{"period":"6month","weight":0.0296},{"period":"1year","weight":-0.0058},{"period":"ytd","weight":0.0413}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0256},{"period":"3month","weight":0.0101},{"period":"6month","weight":0.1519},{"period":"1year","weight":0.1514},{"period":"ytd","weight":0.1547}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"辽宁成大生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24286人(较上一季度减少4.17%)","perCapita":"17147股","listingDate":"2021-10-28","address":"辽宁省沈阳市浑南区新放街1号","registeredCapital":"41645万元","survey":" 辽宁成大生物股份有限公司的主营业务是人用疫苗的研发、生产与销售。公司的主要产品是人用狂犬病疫苗和人用乙脑灭活疫苗。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"成大生物(688739)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供成大生物(688739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"成大生物,688739,成大生物股票,成大生物股票老虎,成大生物股票老虎国际,成大生物行情,成大生物股票行情,成大生物股价,成大生物股市,成大生物股票价格,成大生物股票交易,成大生物股票购买,成大生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"成大生物(688739)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供成大生物(688739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}